Pharmacist-led medication review for knee pain in older adults: Content, process and outcomes

International Journal of Pharmacy Practice

Volumn 16, Issue 6, 2008, Pages 347-355

  Phelan, Mike ^a   Blenkinsopp, Alison ^a   Foster, Nadine E ^a   Thomas, Elaine ^a   Hay, Elaine M ^a  

^a KEELE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACECLOFENAC; ACETYLSALICYLIC ACID; ANALGESIC AGENT; CYCLOOXYGENASE 2 INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LACTULOSE; NARCOTIC ANALGESIC AGENT; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; RALOXIFENE;

ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DROWSINESS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL SYMPTOM; GENERAL PRACTICE; GENERAL PRACTITIONER; HUMAN; INTERDISCIPLINARY COMMUNICATION; KNEE PAIN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PAIN ASSESSMENT; PATIENT EDUCATION; PATIENT REFERRAL; PHARMACEUTICAL CARE; PHARMACIST; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT PLANNING;

EID: 57049092908     PISSN: 09617671     EISSN: None     Source Type: Journal    
DOI: 10.1211/ijpp.16.6.0003     Document Type: Article

References (21)

1. Zermansky AG, Petty DR, Raynor DK, Freemantle N, Vail A, Lowe CJ. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ 2001;323:1-5.
2. Spinewine A. Appropriate use of medicines in patients with rheumatoid arthritis, osteoarthritis and osteoporosis-pharmacists' role. J Phann Belg 2005;60(1):17-22.
3. Osterhaus JT, Dedhiya SD, Ernst ME, Osterhaus M, Mehta SS, Townsend RJ. Health outcomes assessment in community pharmacy practices: a feasibility project. Arthritis Rheum 2002;47(2):124-31.
4. Read RW, Krska J. Targeted medication review: patients in the community with chronic pain. Int J Pharm Pract 1998;6:216-22.
5. Petty DR, Zermansky AG, Lowe CJ, Raynor DK. Pharmacist-conducted clinical medication review clinic: consultation generator or saver? Pharm J (Suppl) 2000;265:R29.
6. Nair K, Dolovich L, Cassels A et al. What patients want to know about their medications. Focus group study of patient and clinician perspectives. Can Fam Physician 2002;48:104-10.
7. Blenkinsopp A, Phelan M, Bourne J, Dakhil N. Extended adherence support by community pharmacists for patients with hypertension: a randomised controlled trial. Int J Pharm Pract 2000;8:165-75.
8. Fraenkel L, Bogardus Jr ST, Concato J, Wittink DR. Treatment options in knee osteoarthritis: the patient's perspective. Arch Intern Med 2004;164(12):1299-1304.
9. Hay EM, Foster N, Thomas E et al. Effectiveness of community physiotherapy and enhanced pharmacy review for knee pain in people aged over 55 presenting to primary care: pragmatic randomised trial. BMJ 2006;333:995.
10. Bellamy N. WOMAC osteoarthritis index: a user's guide. Ontario: London Health Services, McMaster University, 1996.
11. McDermott ME, Smith BH, Elliott AM, Bond CM, Hannaford PC, Chambers WA. The use of medication for chronic pain in primary care, and the potential for intervention by a practice-based pharmacist. Fam Pract 2006;23(1):46-52.
12. Petty DR, Zermansky AG, Raynor DK, Lowe CJ, Freemantle N, Vail A. Clinical medication review by a pharmacist of elderly patients on repeat medications in general practice-pharmacist interventions and review of outcomes. Int J Pharm Pract 2002;10:39-45.
13. Mackridge AJ, Marriott JF, Langley CA. Unused medicines with potential for misuse or abuse in primary care. Int J Pharm Pract 2007;15:229-33.
14. Braybrook S, John DN, Leong K. A survey of why medicines are returned to pharmacies. Pharm J 1999;263:7063.
15. Read RW, Krska J. Potential roles of the pharmacist in chronic pain management: a multidisciplinary perspective in primary care. Int J Pharm Pract 1998;6:223-8.
16. Department of Health. Implementing the new community pharmacy contractual framework. London: The Stationery Office, 2005.
17. Pharmacy Council of New Zealand. Medicines management: definitions, levels and competence framework. http://www.pharmacycouncil.org.nz/ pharmacists/standard/documents/PCNZMedMgmtFramework0407.pdf (accessed April 24, 2008).
18. Pharmacy Guild of Australia/Pharmaceutical Society of Australia. Backgrounder: Patient Medication Profile Program. http:// www.guild.org.au/uploadedfiles/National/Public/News∠d_Events/ Media_Release_Archive/PMP_Backgrounder_18_3_081%20FINAL.pdf (accessed August 12, 2008).
19. Bayrakatar A, Hudson S, Watson A, Fraser S. Pharmaceutical care (7) Arthritis. Pharm J 2000;264:57-68.
20. Department of Health. Pharmacy in England: building on strengths - delivering the future. http://www.dh.gov.uk/en/Publicationsandstatistics/ Publications/PublicationsPolicyAndGuidance/DH_083815 (accessed August 12, 2008).
21. Department of Health. Burnham unveils faster orthopaedic treatment plan. http://www.gnn.gov.uk/Content/ Detail.asp?ReleaseID=238864&NewsAreaID=2 (accessed August 12, 2008).